Brazilian association of national pharmaceutical manufacturers
Brazilian association of national pharmaceutical manufacturers
Brazil’s health regulator has approved five new semaglutide injection pens for diabetes treatment, intensifying competition against Novo Nordisk as the molecule’s patent expired in March 2026.
You must be logged in to post a comment.